Journal profile · Medicine-Internal Medicine
Diabetes Epidemiology and Management
ISSN 2666-9706 · Elsevier · France
Diabetes Epidemiology and Management: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.2 (journal website); fully open access; APC charged, amount not published; review about 26 days (submission to acceptance, publisher); 36 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Diabetes Epidemiology and Management is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes Treatment and Management and Diabetes, Cardiovascular Risks, and Lipoproteins, together about 35.9% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Spin off title published in association with Diabetes & MetabolismDiabetes Epidemiology & Management is a peer-reviewed gold open-access e-only publication. The journal welcomes original articles, reviews and meta-analyses, pilot studies, reports that assess drug and medical device safety and tolerability in all phases of development. The Editors will especially encourage the publication of real-world data and papers on digital technologies, medical devices for diabetes using the data driven approach based on artificial intelligence, leading to remote monitoring and thus be able to cover new grounds with the journal. New formulations and changes in practice guidelines and standards are also welcome for publication. Viewpoints, editorials and research letters will complete the editorial offer.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Internal Medicine
Editor-in-chief Fabrice BonnetPublisher website
Editorial board by country: none in mainland China; most named France 11, Canada 4, Belgium 3, United States 2, Italy 1 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine14.9%
- Diabetes Treatment and ManagementMedicine10.9%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine10%
- Diabetes Management and EducationMedicine9.1%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology6.5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.9%
- Pancreatic function and diabetesMedicine4.7%
- Chronic Disease Management StrategiesMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 3.4LetPub ·
- CiteScore (publisher)
- 3.4Publisher website ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 0.67LetPub ·
- h-index
- 17OpenAlex ·
- i10-index
- 41OpenAlex ·
- 2-year mean citedness
- 1.31OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 26LetPub ·
Articles by year OpenAlex count · 258 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 35 | 9 |
| 2025 | 36 | 36 | 21 |
| 2024 | 42 | 42 | 118 |
| 2023 | 54 | 54 | 315 |
| 2022 | 57 | 57 | 328 |
| 2021 | 34 | 34 | 283 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
26 dayssubmission to acceptance · community reports about 7 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 7 weeksLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- First decision after review
- 33 daysPublisher website ·
- Submission to acceptance
- 26 daysPublisher website ·
- Acceptance to publication
- 1 daysPublisher website ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,000 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,460 / EUR 2,300 / GBP 1,970 / JPY 305,110 | — | — | |
| LetPub | EUR 2,000 | Yes | — | |
| Publisher website | USD 3,080 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
Article types accepted4
- case reportContributions may be submitted in the form of:Original articlesshould not exceed 4 000 words, can include up to 6 tables and/or figures and a maximum of 40 refe…Length not stated
- letterContributions may be submitted in the form of:Original articlesshould not exceed 4 000 words, can include up to 6 tables and/or figures and a maximum of 40 refe…Length not stated
- reviewContributions may be submitted in the form of:Original articlesshould not exceed 4 000 words, can include up to 6 tables and/or figures and a maximum of 40 refe…Length not stated
- viewpointsViewpointsaddress any important topic and are not linked to a specific article or include research data. They should not have more than 3 authors. The maximum l…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- France
- Language
- English
- ISSN
- 2666-9706
- Society / sponsor
- Diabetes & Metabolism
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Diabetes Epidemiology and Management
What CAS zone is Diabetes Epidemiology and Management in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetes Epidemiology and Management is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetes Epidemiology and Management?
The journal's website gives an impact factor of 2.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.4, h-index 17.
How long does peer review take at Diabetes Epidemiology and Management?
The publisher reports about 26 days (submission to acceptance); authors report an average review time of about 7 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Diabetes Epidemiology and Management?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Diabetes Epidemiology and Management based?
Of the 23 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (11), Canada (4) and Belgium (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Diabetes Epidemiology and Management?
According to LetPub and DOAJ records, Diabetes Epidemiology and Management is indexed in ESCI, Scopus and DOAJ.
Is Diabetes Epidemiology and Management open access, and what is the APC?
Diabetes Epidemiology and Management is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .